![]()
|
|
||||||||
J Biol Chem, Vol. 274, Issue 42, 30163-30168, October 15, 1999
From the Department of Cell Biology and Neuroscience, University of
Texas Southwestern Medical School, Dallas, Texas 75235-9039
Previous research suggested the possibility that
contraction of floating collagen matrices by human fibroblasts required
increased myosin light chain (MLC) phosphorylation. In the current
studies, we show that increased MLC phosphorylation was neither
necessary for platelet-derived growth factor
(PDGF)-dependent matrix contraction nor sufficient for
lysophosphatidic acid (LPA)-dependent contraction. In
contrast, increased MLC phosphorylation did appear to be coupled to the
formation of stress fibers by cells spreading in monolayer culture.
Signal transduction pathways required for PDGF- and
LPA-dependent matrix contraction involved
phosphatidylinositol 3-kinase and the Gi class of
heterotrimeric G proteins, respectively. Our results indicate that
PDGF- and LPA-dependent contraction of floating collagen
matrices can be uncoupled from an increase in MLC phosphorylation.
Cellular reorganization of extracellular matrix is a key feature
of morphogenetic processes such as occur during development and wound
repair. Studies on wound repair in vivo suggest that two
fundamentally different mechanisms of matrix reorganization might
result in wound contraction. One depends on migration of cells into the
wound region at the wound margins (1); the other depends on smooth
muscle-like contraction of cells after they have formed the new wound
tissue (i.e. granulation tissue) (2).
To learn more about the mechanisms of matrix reorganization involved in
wound contraction, we and others have been studying model systems in
which fibroblasts contract collagen matrices in vitro (3).
Depending upon whether the matrices are mechanically unloaded or
loaded, contraction occurs, respectively, as a consequence of cell
migration (4, 5) or smooth muscle-like contraction (6, 7).
The signal transduction mechanisms that regulate matrix contraction are
only beginning to be understood. Recently, we showed that in the case
of mechanically unloaded (i.e. "floating") collagen matrices, platelet-derived growth factor
(PDGF)1 and lysophosphatidic
acid (LPA) stimulate contraction by different signaling pathways.
LPA-dependent contraction was selectively inhibited by
pertussis toxin (PTx), whereas PDGF-dependent contraction was selectively inhibited by the protein kinase inhibitor KT5926 (8).
KT5926 has been reported to block myosin light chain (MLC) kinase (9),
the enzyme that promotes muscle contraction by phosphorylating MLC (10,
11). A variety of studies have implicated MLC phosphorylation in the
contractile activity of non-muscle cells (12-15). One interpretation of our previous observations, therefore, was that PDGF (but not LPA)
stimulated contraction by activating MLC kinase leading to MLC
phosphorylation. A role for MLC kinase and MLC phosphorylation also was
suggested based on the ability of cyclic AMP to inhibit collagen matrix
contraction and the assumption that the mechanism of inhibition
involved negative regulation of MLC kinase by cyclic AMP-dependent protein kinase (16-18).
In the present studies, we examined more directly the relationship
between MLC phosphorylation and the contraction of floating collagen
matrices. Contrary to the above hypothesis, our data suggest that PDGF
and LPA stimulation of contraction can be uncoupled from an
increase in MLC phosphorylation.
Materials--
PDGF (BB isotype) was obtained from Upstate
Biotechnology, Inc., Lake Placid, NY. Fatty acid-free bovine serum
albumin, forskolin, dibutyryl cAMP, LPA, and soybean trypsin inhibitor
were purchased from Sigma. Dulbecco's modified Eagle's medium (DMEM)
and trypsin/EDTA solution were obtained from Life Technologies, Inc.
Fetal bovine serum was from Intergen Co., Purchase, NY. Vitrogen
"100" collagen was obtained from Collagen Corp., Palo Alto, CA.
Horseradish peroxidase-conjugated anti-mouse IgG (goat), horseradish
peroxidase-conjugated anti-rabbit IgG (goat), ultrapure glycerol, and
ultrapure urea were obtained from ICN, Aurora, OH. Enhanced
chemiluminescence Western blotting reagent was from Amersham Pharmacia
Biotech. PTx, wortmannin, and LY294002 were obtained from Calbiochem.
Rhodamine-conjugated phalloidin was from Molecular Probes, Eugene, OR.
Fluoromount G was obtained from Southern Biotechology Associates,
Birmingham, AL. Fibronectin was obtained from the New York Blood
Center. Smooth muscle anti-MLC monoclonal antibody (19) was obtained
from the laboratory of Dr. Kristine E. Kamm (University of Texas Southwestern).
Cell Culture--
Fibroblasts from human foreskin specimens
(<10th passage) were maintained in Falcon 75-cm2 tissue
culture flasks in DMEM supplemented with 10% fetal bovine serum.
Fibroblasts were harvested from monolayer culture with 0.25% trypsin
and 1 mM EDTA. Trypsin was neutralized with soybean trypsin
inhibitor (3.3 mg/ml). For contraction experiments, collagen matrices
containing cells were polymerized as described below. For monolayer
culture experiments, harvested cells were incubated for 60 min at
37 °C in Falcon T-75 flasks (5 ml, 105 cells/ml) or on
22-mm2 glass coverslips (0.5 ml, 105 cells/ml).
The culture flasks and coverslips were previously coated for 20 min
with 20 µg/ml fibronectin or 50 µg/ml collagen and then rinsed with
Dulbecco's phosphate-buffered saline (DPBS) (1 mM
CaCl2, 0.5 mM MgCl2, 150 mM NaCl, 3 mM KCl, 1 mM
KH2PO4, 6 mM
Na2HPO4, pH 7.2). To load fibroblasts in
monolayer culture with PTx, the cells were incubated overnight in DMEM
and 10% fetal bovine serum containing PTx at the concentrations indicated.
Collagen Matrix Contraction--
Contraction of floating
collagen matrices was carried out as described previously (8).
Neutralized solutions of Vitrogen "100" collagen (1.5 mg/ml) were
prepared containing fibroblasts (106 cells/ml) in DMEM
without serum. The cell/collagen mixture was prewarmed to 37 °C for
3-4 min, and 0.2-ml aliquots were placed in Corning 24-well culture
plates. Each aliquot occupied an area outlined by an 11-mm diameter
circular score within a well. Polymerization of collagen matrices
required 60 min at 37 °C. To initiate matrix contraction, matrices
were released gently from the underlying culture dish with a spatula
into 0.5-1 ml of serum-free DMEM containing 5 mg/ml bovine serum
albumin with growth factors and inhibitors added as indicated, after
which the matrices were incubated at 37 °C.
To determine the extent of floating matrix contraction, samples were
fixed with 3% paraformaldehyde in phosphate-buffered saline (PBS) (150 mM NaCl, 3 mM KCl, 1 mM
KH2PO4, 6 mM
Na2HPO4, pH 7.2) for 20 min at 22 °C. The
matrices were washed, placed on a flat surface, and measured with a
ruler. For quantitative purposes, contraction data are presented as the
change in diameter (starting Myosin Light Chain Phosphorylation--
MLC phosphorylation was
determined using the urea/glycerol-PAGE method (20, 21). Cells in T-75
flasks were treated with ice-cold 10% (w/v) trichloroacetic acid
containing 10 mM dithiothreitol, scraped off the dishes,
and homogenized on ice using ~100 strokes with a Dounce homogenizer
(Wheaton, tight pestle). After centrifugation at 8,000 rpm (Beckman
Microfuge) for 1 min at 4 °C, the pellets were washed three times
with diethylether, dissolved in urea-sample buffer (10 mM
dithiothreitol, 0.004% bromphenol blue, 8 M urea, 20 mM Tris, and 23 mM glycine, pH 8.6), and
resuspended using a water bath sonicator (Branson 2210) for 10 min.
Samples were subjected to urea/glycerol-PAGE using 10% gels. Transfer
to polyvinylidene difluoride was carried out for 2 h at 50 V. Blots were fixed with 0.4% glutaraldehyde in PBS for 30 min at
22 °C and washed three times in PBS, blocked with 5% milk in TTBS
(0.1% Tween 20, 150 mM NaCl, 20 mM Tris, pH
7.5), and then incubated with anti-MLC monoclonal antibody in blocking
solution at 4 °C for 12 h. After washing in TTBS, membranes
were incubated with horseradish peroxidase-conjugated goat anti-mouse
IgG in 3% bovine serum albumin and TTBS at 22 °C for 2 h and
then visualized by enhanced chemiluminescence. Quantitative evaluation
of the nonphosphorylated, monophosphorylated, and diphosphorylated MLC
was performed by densitometric analysis using NIH Image.
Fluorescence Microscopy of the Actin Cytoskeleton--
Cells on
coverslips were fixed for 20 min at 22 °C with 3% paraformaldehyde
in DPBS, blocked with 1% glycine and 1% bovine serum albumin in DPBS
for 30 min, and permeabilized with 0.2% Nonidet P-40 in DPBS for 10 min. To stain for actin, samples were incubated with
rhodamine-conjugated phalloidin (8 units/ml) for 30 min at 37 °C.
After washing in DPBS, slides were mounted with Fluoromount G. Images
were observed and captured using a Olympus BH2-RFCA fluorescence
microscope equipped with a Hamamatsu C5985-02 cooled CCD camera.
Cyclic AMP Selectively Inhibits PDGF-dependent Matrix
Contraction--
Fig. 1 shows the
results of a typical floating matrix contraction experiment. With no
growth factors added (basal contraction), the matrix diameter decreased
~1-2 mm (initially ~10.5 mm). With growth factors LPA or PDGF, the
diameter decreased 4-6 mm. When cells in polymerized matrices were
treated with increasing concentrations of forskolin for 10 min before
the addition of growth factors, there was a dose-dependent
inhibition of PDGF-dependent matrix contraction but little
effect on LPA-dependent contraction. Forskolin also
inhibited basal contraction. Fig. 2 shows
that a similar pattern of inhibition was observed when the cells were
treated with dibutyryl cyclic AMP rather than forskolin. It should be noted that incubation of fibroblasts in collagen matrices with 10 µM forskolin for 10 min results in a 3-fold activation of
cyclic AMP-dependent protein kinase (22).
Growth Factor Stimulation of Contraction Does Not Correlate with
MLC Phosphorylation--
Experiments were then carried out to learn if
cyclic AMP blocked PDGF-dependent contraction through
an effect on MLC phosphorylation. Preliminary experiments with cells in
collagen matrices failed for technical reasons. The MLC phosphorylation
assays required ~3 × 106 cells/sample, whereas each
collagen matrix contains only 2 × 105 cells, and the
presence of collagen extracted from the matrix was found to interfere
with the urea/glycerol gels. Subsequently, MLC phosphorylation assays
were carried out using cells attached to culture dishes. Essentially
identical results were observed with cells on fibronectin-coated or
collagen-coated dishes (not shown).
To mimic the timing of collagen matrix contraction, freshly harvested
fibroblasts were allowed to attach to the culture dishes for 1 h,
treated with or without forskolin for 15 min, and then with LPA or
PDGF. Fig. 3A shows that after
15 min of growth factor treatment, the monophosphorylated and
diphosphorylated forms of MLC were readily distinguished based on the
faster molecular mobility in urea gels of the phosphorylated molecules
(20, 21). Fig. 3B presents quantitative evaluation of the
results.
In the absence of growth factors, the basal level of MLC
phosphorylation was 10-20%. In response to PDGF stimulation, MLC phosphorylation typically decreased slightly. Even if MLC
phosphorylation was measured 5 min after the addition of PDGF, no
increase was detected (not shown). Therefore, the PDGF signaling
pathway in human fibroblasts did not appear to be linked to MLC
phosphorylation, which argued against a role for MLC kinase in
PDGF-dependent stimulation of collagen matrix contraction.
In marked contrast, incubation of cells with LPA resulted in a
stimulation of MLC phosphorylation with increased levels of both
monophosphorylated and diphosphorylated forms of the molecule. In this
case, prior forskolin treatment decreased the stimulatory effect of LPA
(Fig. 3, A and B), even though forskolin had
little effect on LPA-stimulated contraction (Fig. 1). Therefore,
although LPA stimulated MLC phosphorylation, the relationship of this
stimulation to collagen matrix contraction was questionable (see below).
We also measured the pattern of MLC phosphorylation in cells that were
stimulated 1 h or 4 h with or without growth factors. Fig.
4 shows that by 1 h, the extent of
MLC phosphorylation had increased even in the absence of growth factor
addition. LPA-treated samples still, however, showed a higher degree of
phosphorylation than the untreated or PDGF-treated cultures. By 4 h, the LPA-stimulated increase had begun to decline, and similar levels
of MLC phosphorylation were apparent at this time under all incubation
conditions.
Forskolin-induced Arborization of the Actin Cytoskeleton Was
Reversed by LPA but Not by PDGF--
To correlate the changes in MLC
phosphorylation with organization of the cells' actin cytoskeleton,
observations also were made on fibroblasts that were fixed and stained
with phalloidin. Cells behaved similarly on fibronectin or
collagen-coated coverslips (not shown). Fig.
5 shows that in the absence of added
growth factors, fibroblasts were able to attach, spread, and form some stress fibers over 2 h. PDGF increased membrane ruffling. LPA increased actin stress fiber formation.
Treatment of the cells with forskolin caused the actin cytoskeleton to
develop an arborized appearance. This change in the cytoskeleton
occurred within 10-15 min after the addition of forskolin and was
evident before growth factors were added (not shown). Incubation of
forskolin-treated cells with LPA but not PDGF was able to reverse the
arborized morphology, although the density of actin stress fibers was
less than that observed in cells treated with LPA alone.
Pertussis Toxin Inhibits LPA-dependent Contraction
without Blocking LPA-dependent MLC
Phosphorylation--
The ability of LPA to promote MLC phosphorylation
and assembly of stress fibers is consistent with previous studies that
demonstrated an LPA-activated, Rho-dependent mechanism of
contraction (13, 23-25). Rho-dependent contraction has
been shown to be PTx-insensitive (26, 27), however, whereas
LPA-dependent contraction of floating collagen matrices was
PTx-sensitive (8). Therefore, experiments were carried out to compare
the effects of PTx treatment on matrix contraction and MLC phosphorylation.
As shown in Fig. 6, prior treatment of
fibroblasts with PTx selectively inhibited LPA-dependent
contraction but had little effect on PDGF-dependent
contraction. Similar results were found using concentrations of PTx
ranging from 25 to 100 ng/ml (not shown). Fig.
7, on the other hand, shows that unlike
forskolin, PTx did not alter the ability of LPA to stimulate MLC
phosphorylation. Other experiments demonstrated that PTx treatment did
not alter the ability of cells to spread and form stress fibers (not
shown). These findings suggested that LPA stimulated two sets of
receptors, one of which was part of a PTx-sensitive pathway required
for matrix contraction, and the other part of a PTx-insensitive pathway leading to MLC phosphorylation and stress fiber formation.
Blocking Phosphatidylinositol 3-Kinase (PI3 Kinase) Selectively
Inhibits PDGF-dependent Matrix Contraction--
The
foregoing results suggested that PDGF and LPA stimulation of
contraction could be uncoupled from increased MLC phosphorylation. Consequently, we began to examine the role of other signaling pathways
in contraction. As was shown in Fig. 5, cell membrane ruffling
increased in response to PDGF. Because PDGF-dependent ruffling requires activation of the enzyme PI3-kinase (28), we tested
the possibility that PI3-kinase stimulation might be required for
contraction. Fig. 8 shows that the
concentrations of wortmannin and LY294002 which blocked PI3-kinase
activity blocked PDGF-dependent collagen matrix
contraction. In marked contrast, as shown in Fig.
9, neither wortmannin nor LY294002
interfered with LPA-dependent collagen matrix contraction.
These results suggested a role for PI3-kinase in PDGF- but not
LPA-dependent contraction.
Our studies were carried out to investigate the relationship
between PDGF- and LPA-dependent matrix contraction and the
ability of these growth factors to stimulate MLC phosphorylation. As
discussed in more detail below, increased MLC phosphorylation is
neither necessary for PDGF-dependent matrix contraction nor
sufficient for LPA-dependent contraction. On the other
hand, increased MLC phosphorylation appears to be correlated with
formation of stress fibers by cells spreading in monolayer culture. Our
findings suggest that the signal transduction pathways required for
PDGF- and LPA-dependent matrix contraction involve
PI3-kinase and the Gi class of heterotrimeric G proteins,
respectively, whereas LPA-dependent stress fiber formation and MLC phosphorylation involve the small G protein Rho. Overall, the
results suggest that growth factor-dependent contraction of floating collagen matrices is uncoupled from an increase in MLC phosphorylation. They do not exclude the possibility, however, that MLC
phosphorylation plays a permissive role in contraction.
A role for MLC phosphorylation in collagen matrix contraction was
suggested previously based on inhibition of contraction by cyclic AMP
(16-18). The current studies confirm that cyclic AMP can regulate
contraction, at least contraction dependent on PDGF, but the mechanism
of regulation does not appear to require MLC phosphorylation, because
an increase in MLC phosphorylation did not occur when the cells were
treated with PDGF. In fact, PDGF treatment caused a slight decrease in
MLC phosphorylation, at least transiently.
It should be noted that fibroblasts in collagen matrices can be
stimulated to increase their level of MLC phosphorylation when they
exert increased isometric force (29, 30), and under these conditions
the cells form prominent stress fibers (6, 7, 31). In marked contrast,
fibroblasts in floating collagen matrices remain mechanically unloaded
throughout contraction, unable to form stress fibers or fibronexus
junctions (32).
Cell membrane ruffling stimulated by PDGF may play an important role in
the migratory activity required for floating matrix contraction.
PDGF-induced membrane ruffling depends on PI3-kinase (28), and blocking
PI3-kinase also prevented matrix contraction. At high concentrations of
PDGF, the inhibition by PI3-kinase inhibitors appeared to be overcome,
at least partially. Interestingly, smooth muscle contraction that is
independent of MLC phosphorylation has been reported to involve the
protein kinase PAK (33), and PAK has been implicated in cell membrane
ruffling as well (34-36). While our studies were in progress, two
other laboratories also showed that blocking PI3-kinase inhibits
PDGF-dependent collagen matrix contraction (37, 38).
Unlike PDGF, LPA stimulated both matrix contraction and MLC
phosphorylation. The evidence suggests that different signaling pathways were involved, however. LPA activates receptors linked to
PTx-sensitive (Gi) and -insensitive (Gq and
G12/13) heterotrimeric G proteins (27). Matrix contraction
appeared to require the former; MLC phosphorylation the latter.
LPA-dependent, PTx-insensitive, MLC phosphorylation and
stress fiber formation have been shown to depend on activation of the
small G protein Rho (12-15) by G13-coupled LPA receptors
(39-41). In agreement with these previous findings, we observed a
correlation between MLC phosphorylation and stress fiber formation;
that is, LPA stimulated both MLC phosphorylation and stress fiber
formation. Moreover, both the basal level of MLC phosphorylation and
stress fiber formation were decreased when cells were treated with
forskolin, presumably a result of negative regulation of Rho (42-44).
As in the case of smooth muscle, where agonist-stimulated MLC
phosphorylation is transient although contractile force is sustained
(45, 46), LPA stimulation of MLC phosphorylation in fibroblasts
appeared to decline by 4 h after stimulation.
In marked contrast to the above pathway, little is known about the
LPA-dependent, PTx-sensitive mechanism of floating matrix contraction (8 and current studies) other than the presumed involvement of the Gi class of heterotrimeric G proteins. Whatever the
precise mechanism, the pathway also is likely to be important in other aspects of fibroblast migration and chemotaxis (47, 48). This pathway
clearly differs from routine cell spreading and stress fiber formation,
however, because fibroblasts were able to spread and form stress fibers
on protein-coated surfaces under conditions that matrix contraction did
not occur (e.g. in the absence of added growth factors or
with the combination of LPA and PTx).
Cyclic AMP inhibition of PDGF but not LPA-dependent matrix
contraction provided further evidence that these growth factors regulate collagen matrix contraction by different signaling mechanisms. The site at which cyclic AMP regulates PDGF-dependent
contraction is likely downstream of PI3-kinase. We cannot exclude,
however, the possibility that cyclic AMP regulation of
PDGF-dependent contraction also occurs at the level of Rho
because PDGF-dependent contraction was inhibited by C3
exotransferase (8).
In summary, our studies suggest that extracellular matrix
reorganization leading to contraction of floating collagen matrices occurs by a cell migratory mechanism that can be uncoupled from MLC
phosphorylation. Although much is known about the regulatory mechanisms
that control cell migration (49, 50), most of our understanding comes
from monolayer experiments in which there is a competition between
adhesion and migration (51). In mechanically unloaded collagen
matrices, where stress fibers and fibronexus junction cannot form (32),
far different constraints on cell migration likely apply.
We are indebted to Drs. Kristine Kamm, Robert
Wysolmerski, Michael White, William Snell, Hans Rosenfeldt, David Lee,
Jeanne Fringer, and Meifang Zhu for advice and assistance regarding our research.
*
This work was supported by National Institutes of Health
Grant GM31321.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Dept. of Cell Biology
and Neuroscience, University of Texas Southwestern Medical School, 5323 Harry Hines Blvd., Dallas, TX 75235-9039. Tel.: 214-648-2181; Fax:
214-648-8694; E-mail: frederick.grinnell@email.swmed.edu.
The abbreviations used are:
PDGF, platelet-derived growth factor;
LPA, lysophosphatidic acid;
PTx, pertussis toxin;
MLC, myosin light chain;
DMEM, Dulbecco's modified
Eagle's medium;
PBS, phosphate-buffered saline;
DPBS, Dulbecco's
phosphate-buffered saline;
PAGE, polyacrylamide gel electrophoresis;
PI3-kinase, phosphatidylinositol 3-kinase.
Increased Myosin Light Chain Phosphorylation Is Not Required for
Growth Factor Stimulation of Collagen Matrix Contraction*
,
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
final) measured in mm. All
experiments were carried out in duplicate, and every experiment was
repeated two or more times. Data points and error bars in the figures
represent averages and standard deviations. Where error bars cannot be
seen, the data points overlapped.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (22K):
[in a new window]
Fig. 1.
Effect of forskolin on matrix contraction
promoted by LPA and PDGF. Collagen matrices polymerized for 1 h were incubated with forskolin for 10 min at the concentrations
indicated, released, and incubated for 4 h with 100 ng/ml PDGF or
10 µM LPA added where shown. At the end of the
incubations, matrix contraction was measured as the decrease in matrix
diameter.

View larger version (22K):
[in a new window]
Fig. 2.
Effect of dibutyryl cyclic AMP on matrix
contraction promoted by LPA and PDGF. Collagen matrices
polymerized for 1 h were incubated with dibutyryl cyclic AMP for
10 min at the concentrations indicated, released, and incubated for
4 h with 100 ng/ml PDGF or 10 µM LPA added where
shown. At the end of the incubations, matrix contraction was measured
as the decrease in matrix diameter.

View larger version (34K):
[in a new window]
Fig. 3.
Effect of forskolin, LPA, and PDGF on MLC
phosphorylation. Panel A, fibroblasts were incubated
for 1 h in fibronectin-coated T-75 flasks, treated with 15 µM forskolin as indicated for 15 min, and then with LPA
or PDGF for 15 min as shown. At the end of the incubations, cells were
harvested, subjected to urea/glycerol-PAGE, and immunoblotted with
antibodies to MLC. Positions of nonphosphorylated, monophosphorylated,
and diphosphorylated MLC were determined relative to a smooth muscle
MLC standard. Panel B, averages and S.D. from three separate
experiments as in panel A in which band densities were
analyzed using NIH Image.

View larger version (39K):
[in a new window]
Fig. 4.
MLC phosphorylation after 1-4-h stimulation
with LPA or PDGF. Fibroblasts were incubated for 1 h in
fibronectin-coated T-75 flasks and treated with LPA or PDGF for 1 h or 4 h as indicated. At the end of the incubations, cells were
harvested, subjected to urea/glycerol-PAGE, and immunoblotted with
antibodies to MLC. Positions of nonphosphorylated, monophosphorylated,
and diphosphorylated MLC were determined relative to a smooth muscle
MLC standard.

View larger version (149K):
[in a new window]
Fig. 5.
Effect of forskolin, LPA, and PDGF on cell
spreading and actin organization. Fibroblasts were incubated for
1 h on fibronectin-coated coverslips, treated with 15 µM forskolin as indicated for 15 min, and then with LPA
(10 µM) or PDGF (100 ng/ml) for 1 h as shown. At the
end of the incubations, cells were fixed and stained with rhodamine
phalloidin to visualize actin.

View larger version (34K):
[in a new window]
Fig. 6.
Effect of PTx on contraction of floating
matrices stimulated by PDGF and LPA. Fibroblasts were incubated
overnight with 25 ng/ml PTx as indicated. Subsequently, the cells were
harvested and tested for contraction of floating matrices for 4 h
in the presence of PDGF (100 ng/ml) and LPA (10 µM) as
shown.

View larger version (33K):
[in a new window]
Fig. 7.
Effect of PTx, forskolin, and LPA on MLC
phosphorylation. Fibroblasts were incubated overnight with 50 ng/ml PTx as indicated. Subsequently, the cells were harvested and
incubated for 1 h in fibronectin-coated T-75 flasks, treated with
15 µM forskolin as indicated for 15 min, and then with
LPA (10 µM) for 15 min as shown. At the end of the
incubations, cells were harvested, subjected to urea/glycerol-PAGE, and
immunoblotted with antibodies to MLC. Positions of nonphosphorylated,
monophosphorylated, and diphosphorylated MLC were determined relative
to a smooth muscle MLC standard.

View larger version (47K):
[in a new window]
Fig. 8.
Effect of wortmannin and LY294002 on matrix
contraction promoted by PDGF. Collagen matrices polymerized for
1 h were incubated with 1 µM wortmannin or 20 µM LY294002 for 1 h as indicated, released, and
incubated for 4 h with PDGF at the concentrations shown. At the
end of the incubations, matrix contraction was measured as the decrease
in matrix diameter.

View larger version (51K):
[in a new window]
Fig. 9.
Effect of wortmannin and LY294002 on matrix
contraction promoted by LPA. Collagen matrices polymerized for
1 h were incubated with 1 µM wortmannin or 20 µM LY294002 for 1 h as indicated, released, and
incubated 4 h with 10 µM LPA. At the end of the
incubations, matrix contraction was measured as the decrease in matrix
diameter.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
Paper submitted in partial fulfillment of the requirements for the
Ph.D. degree in the Dept. of Biochemistry, University Medical School of
Pecs, Hungary.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
1.
Gross, J.,
Farinelli, W.,
Sadow, P.,
Anderson, R.,
and Bruns, R.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
5982-5986 2.
Desmoulière, A.,
and Gabbiani, G.
(1996)
in
The Molecular and Cellular Basis of Wound Repair
(Clark, R. A. F., ed), 2nd Ed.
, pp. 391-423, Plenum Press, New York
3.
Grinnell, F.
(1994)
J. Cell Biol.
124,
401-404 4.
Bell, E.,
Ivarsson, B.,
and Merrill, C.
(1979)
Proc. Natl. Acad. Sci. U. S. A.
76,
1274-1278 5.
Ehrlich, H. P.,
and Rajaratnam, J. B.
(1990)
Tissue Cell
22,
407-417[CrossRef][Medline]
[Order article via Infotrieve]
6.
Mochitate, K.,
Pawelek, P.,
and Grinnell, F.
(1991)
Exp. Cell Res
193,
198-207[CrossRef][Medline]
[Order article via Infotrieve]
7.
Tomasek, J. J.,
Haaksma, C. J.,
Eddy, R. J.,
and Vaughan, M. B.
(1992)
Anat Rec.
232,
359-368[CrossRef][Medline]
[Order article via Infotrieve]
8.
Grinnell, F.,
Ho, C.-H.,
Lin, Y.-C.,
and Skuta, G.
(1999)
J. Biol. Chem.
274,
918-923 9.
Nakanishi, S.,
Yamada, K.,
Iwahashi, K.,
Kuroda, K.,
and Kase, H.
(1990)
Mol. Pharmacol.
37,
482-488[Abstract]
10.
Horowitz, A. F. A.,
Menice, C. B.,
Laporte, R.,
and Morgan, K. G.
(1996)
Physiol. Rev.
76,
967-1003 11.
Gallagher, P. J.,
Herring, B. P.,
and Stull, J. T.
(1997)
J. Muscle Res. Cell Motil.
18,
1-16[CrossRef][Medline]
[Order article via Infotrieve]
12.
Kreisberg, J. I.,
and Venkatachalam, M. A.
(1986)
Am. J. Physiol.
251,
C505-C11 13.
Chrzanowska-Wodnicka, M.,
and Burridge, K.
(1996)
J. Cell Biol.
133,
1403-1415 14.
Lamb, N. J.,
Fernandez, A.,
Conti, M. A.,
Adelstein, R.,
Glass, D. B.,
Welch, W. J.,
and Feramisco, J. R.
(1988)
J. Cell Biol.
106,
1955-1971 15.
Goeckeler, Z. M.,
and Wysolmerski, R. B.
(1995)
J. Cell Biol.
130,
613-627 16.
Ehrlich, H. P.,
and Griswold, T. R.
(1984)
J. Invest. Dermatol.
83,
230-233[CrossRef][Medline]
[Order article via Infotrieve]
17.
Ehrlich, H. P.,
Rockwell, W. B.,
Cornwell, T. L.,
and Rajaratnam, J. B. M.
(1991)
J. Cell. Physiol.
146,
1-7[CrossRef][Medline]
[Order article via Infotrieve]
18.
van Bockxmeer, F. M.,
Martin, C. E.,
and Constable, I. J.
(1984)
Exp. Cell Res.
155,
413-421[CrossRef][Medline]
[Order article via Infotrieve]
19.
Lau, K. S.,
Grange, R. W.,
Chang, W. J.,
Kamm, K. E.,
Sarelius, I.,
and Stull, J. T.
(1998)
FEBS Lett.
431,
71-74[CrossRef][Medline]
[Order article via Infotrieve]
20.
Persechini, A.,
Kamm, K. E.,
and Stull, J. T.
(1986)
J. Biol. Chem.
261,
6293-6299 21.
Word, R. A.,
Casey, M. L.,
Kamm, K. E.,
and Stull, J. T.
(1991)
Am. J. Physiol.
260,
C861-C867 22.
He, Y.,
and Grinnell, F.
(1994)
J. Cell Biol.
126,
457-464 23.
Kimura, K.,
Ito, M.,
Amano, M.,
Chihara, K.,
Fukata, Y.,
Nakafuku, M.,
Yamamori, B.,
Feng, J.,
Nakano, T.,
Okawa, K.,
Iwamatsu, A.,
and Kaibuchi, K.
(1996)
Science
273,
245-248[Abstract]
24.
Kureishi, Y.,
Kobayashi, S.,
Amano, M.,
Kimura, K.,
Kanaide, H.,
Nakano, T.,
Kaibuchi, K.,
and Ito, M.
(1997)
J. Biol. Chem.
272,
12257-12260 25.
Tapon, N.,
and Hall, A.
(1997)
Curr. Opin. Cell Biol.
9,
86-92[CrossRef][Medline]
[Order article via Infotrieve]
26.
Nobes, C. D.,
and Hall, A.
(1995)
Cell
81,
53-62[CrossRef][Medline]
[Order article via Infotrieve]
27.
Moolenaar, W. H.,
Kranenburg, O.,
Postma, F. R.,
and Zondag, G. C.
(1997)
Curr. Opin. Cell Biol.
9,
168-173[CrossRef][Medline]
[Order article via Infotrieve]
28.
Wennstrom, S.,
Hawkins, P.,
Cooke, F.,
Hara, K.,
Yonezawa, K.,
Kasuga, M.,
Jackson, T.,
Claesson-Welsh, L.,
and Stephens, L.
(1994)
Curr. Biol.
4,
385-393[CrossRef][Medline]
[Order article via Infotrieve]
29.
Kolodney, M. S.,
and Elson, E. L.
(1993)
J. Biol. Chem.
268,
23850-23855 30.
Kolodney, M. S.,
and Elson, E. L.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
10252-10256 31.
Lin, Y. C.,
Ho, C. H.,
and Grinnell, F.
(1997)
Mol. Biol. Cell
8,
59-71[Abstract]
32.
Halliday, N. L.,
and Tomasek, J. J.
(1995)
Exp. Cell Res.
217,
109-117[CrossRef][Medline]
[Order article via Infotrieve]
33.
Van Eyk, J. E.,
Arrell, D. K.,
Foster, D. B.,
Strauss, J. D.,
Heinonen, T. Y. K.,
Furmaniak-Kazmierczak, E.,
Cote, G. P.,
and Mak, A. S.
(1998)
J. Biol. Chem.
273,
23433-23439 34.
Sells, M. A.,
Knaus, U. G.,
Bagrodia, S.,
Ambrose, D. M.,
Bokoch, G. M.,
and Chernoff, J.
(1997)
Curr. Biol.
7,
202-210
35.
Obermeier, A.,
Ahmed, S.,
Manser, E.,
Yen, S. C.,
Hall, C.,
and Lim, L.
(1998)
EMBO J.
17,
4328-4339[CrossRef][Medline]
[Order article via Infotrieve]
36.
Adam, L.,
Vadlamudi, R.,
Kondapaka, S. B.,
Chernoff, J.,
Mendelsohn, J.,
and Kumar, R.
(1998)
J. Biol. Chem.
273,
28238-28246 37.
Zent, R.,
Ailenberg, M.,
and Silverman, M.
(1998)
Exp. Cell Res.
240,
134-143[CrossRef][Medline]
[Order article via Infotrieve]
38.
Ahlen, K.,
Berg, A.,
Stiger, F.,
Tengholm, A.,
Siegbahn, A.,
Gylfe, E.,
Reed, R. K.,
and Rubin, K.
(1998)
Cell Adhes. Commun.
5,
461-473[Medline]
[Order article via Infotrieve]
39.
Gohla, A.,
Harhammer, R.,
and Schultz, G.
(1998)
J. Biol. Chem.
273,
4653-4659 40.
Kozasa, T.,
Jiang, X.,
Hart, M. J.,
Sternweis, P. M.,
Singer, W. D.,
Gilman, A. G.,
Bollag, G.,
and Sternweis, P. C.
(1998)
Science
280,
2109-2111 41.
Hart, M. J.,
Jiang, X.,
Kozasa, T.,
Roscoe, W.,
Singer, W. D.,
Gilman, A. G.,
Sternweis, P. C.,
and Bollag, G.
(1998)
Science
280,
2112-2114 42.
Lang, P.,
Gesbert, F.,
Delespine-Carmagnat, M.,
Stancou, R.,
Pouchelet, M.,
and Bertoglio, J.
(1996)
EMBO J.
15,
510-519[Medline]
[Order article via Infotrieve]
43.
Laudanna, C.,
Campbell, J. J.,
and Butcher, E. C.
(1997)
J. Biol. Chem.
272,
24141-24144 44.
Dong, J. M.,
Leung, T.,
Manser, E.,
and Lim, L.
(1998)
J. Biol. Chem.
273,
22554-22562 45.
Tang, D. C.,
Stull, J. T.,
Kubota, Y.,
and Kamm, K. E.
(1992)
J. Biol. Chem.
267,
11839-11845 46.
Kamm, K. E.,
and Stull, J. T.
(1985)
Annu. Rev. Pharmacol. Toxicol.
25,
593-620[CrossRef][Medline]
[Order article via Infotrieve]
47.
Lummen, G.,
Virchow, S.,
Rumenapp, U.,
Schmidt, M.,
Wieland, T.,
Otto, T.,
Rubben, H.,
and Jakobs, K. H.
(1997)
Naunyn-Schmiedeberg's Arch. Pharmacol.
356,
769-776[CrossRef][Medline]
[Order article via Infotrieve]
48.
Pietruck, F.,
Busch, S.,
Virchow, S.,
Brockmeyer, N.,
and Siffert, W.
(1997)
Naunyn-Schmiedeberg's Arch. Pharmacol.
355,
1-7[CrossRef][Medline]
[Order article via Infotrieve]
49.
Lauffenburger, D. A.,
and Horwitz, A. F.
(1996)
Cell
84,
359-369[CrossRef][Medline]
[Order article via Infotrieve]
50.
Mitchison, T. J.,
and Cramer, L. P.
(1996)
Cell
84,
371-379[CrossRef][Medline]
[Order article via Infotrieve]
51.
Palecek, S. P.,
Loftus, J. C.,
Ginsberg, M. H.,
Lauffenburger, D. A.,
and Horwitz, A. F.
(1997)
Nature
385,
537-540[CrossRef][Medline]
[Order article via Infotrieve]
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
H. Jiang, S. Rhee, C.-H. Ho, and F. Grinnell Distinguishing fibroblast promigratory and procontractile growth factor environments in 3-D collagen matrices FASEB J, July 1, 2008; 22(7): 2151 - 2160. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H. Wang, H. Tanaka, X. Qin, T. Zhao, L.-H. Ye, T. Okagaki, T. Katayama, A. Nakamura, R. Ishikawa, S. E. Thatcher, et al. Blebbistatin inhibits the chemotaxis of vascular smooth muscle cells by disrupting the myosin II-actin interaction Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2060 - H2068. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rhee and F. Grinnell P21-activated kinase 1: convergence point in PDGF- and LPA-stimulated collagen matrix contraction by human fibroblasts J. Cell Biol., January 30, 2006; 172(3): 423 - 432. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. M. Goeckeler and R. B. Wysolmerski Myosin Phosphatase and Cofilin Mediate cAMP/cAMP-dependent Protein Kinase-induced Decline in Endothelial Cell Isometric Tension and Myosin II Regulatory Light Chain Phosphorylation J. Biol. Chem., September 23, 2005; 280(38): 33083 - 33095. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Emmert, J. A. Fee, Z. M. Goeckeler, J. M. Grojean, T. Wakatsuki, E. L. Elson, B. P. Herring, P. J. Gallagher, and R. B. Wysolmerski Rho-kinase-mediated Ca2+-independent contraction in rat embryo fibroblasts Am J Physiol Cell Physiol, January 1, 2004; 286(1): C8 - C21. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Abe, C.-H. Ho, K. E. Kamm, and F. Grinnell Different Molecular Motors Mediate Platelet-derived Growth Factor and Lysophosphatidic Acid-stimulated Floating Collagen Matrix Contraction J. Biol. Chem., November 28, 2003; 278(48): 47707 - 47712. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Vishwanath, L. Ma, C. A. Otey, J. V. Jester, and W. M. Petroll Modulation of Corneal Fibroblast Contractility within Fibrillar Collagen Matrices Invest. Ophthalmol. Vis. Sci., November 1, 2003; 44(11): 4724 - 4735. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. ROSENFELDT, Y. AMRANI, K. R. WATTERSON, K. S. MURTHY, R. A. PANETTIERI JR, and S. SPIEGEL Sphingosine-1-phosphate stimulates contraction of human airway smooth muscle cells FASEB J, October 1, 2003; 17(13): 1789 - 1799. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Vanni, B. C. Lagerholm, C. Otey, D. L. Taylor, and F. Lanni Internet-Based Image Analysis Quantifies Contractile Behavior of Individual Fibroblasts inside Model Tissue Biophys. J., April 1, 2003; 84(4): 2715 - 2727. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Seasholtz The RHOad less traveled: the myosin phosphorylation-independent path from Rho kinase to cell contraction. : Focus on "Rho kinase mediates serum-induced contraction in fibroblast fibers independent of myosin LC20 phosphorylation" Am J Physiol Cell Physiol, March 1, 2003; 284(3): C596 - C598. [Full Text] [PDF] |
||||
![]() |
Y. Ikuno, F.-L. Leong, and A. Kazlauskas PI3K and PLC{gamma} Play a Central Role in Experimental PVR Invest. Ophthalmol. Vis. Sci., February 1, 2002; 43(2): 483 - 489. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ikuno and A. Kazlauskas TGF{beta}1-Dependent Contraction of Fibroblasts Is Mediated by the PDGF{alpha} Receptor Invest. Ophthalmol. Vis. Sci., January 1, 2002; 43(1): 41 - 46. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||